References

medsovet

Медицинский Совет

Meditsinskiy sovet = Medical Council

2079-701X2658-5790

REMEDIUM GROUP Ltd.

10.21518/2079-701X-2019-13-16-27

medsovet-3801

Research Article

Актуальная проблема

Actual problem

Возможности негормональной коррекции нарушений менструального цикла

Non hormonal management options for menstrual cycle irregularities

https://orcid.org/0000-0001-5541-3767

Кузнецова

И. В.

Kuznetsova

I. V.

Кузнецова Ирина Всеволодовна, доктор медицинских наук, профессор кафедры акушерства и гинекологии №1, Институт клинической медицины

119991, Москва, ул. Трубецкая, д. 8, стр. 2

Irina V. Kuznetsova, Dr. of Sci. (Med.), Professor, Professor of Chair for Obstetrics and Gynecology No. 1, Institute of Clinical Medicine

8, Bldg. 2, Trubetskaya St., Moscow, 119991

ms.smith.ivk@gmail.com

Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University)Russian Federation

2019

09102019

0131627

2019

Кузнецова И.В.

Kuznetsova I.V.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-sovet.pro/jour/article/view/3801

Нарушения ритма менструаций и симптомы, связанные с менструальным циклом, являются одной из главных причин обращения женщин к гинекологу. После исключения эндокринопатий и органических субстратов менструальных нарушений врач встает перед непростой задачей лечения состояний, которые отражают функциональное неблагополучие организма и его приспособление к высокой стрессовой нагрузке. Гормональная терапия, бесспорно, является основным ресурсом врача-гинеколога, но она не всегда приемлема и решает далеко не все задачи по нормализации психонейроэндокринного статуса. Зависимость функциональных нарушений от стрессовых факторов внешней среды позволяет использовать коррекцию образа жизни, включая рациональное питание и дотацию разнообразных микронутриентов, в программе улучшения качества жизни, устранения психоэмоциональных симптомов и признаков вегетативной дисфункции. В свою очередь, восстановление адаптационного резерва организма становится залогом возвращения менструальной функции.

Menstrual rhythm disorders and symptoms associated with the menstrual cycle are one of the main reasons for women to make an appointment with a gynecologist. After the endocrinopathies and organic substrates of menstrual irregularities are excluded, the doctor is faced with the difficult task to treat conditions that reflect the functional dysfunction of the body and its adaptation to high stress load. It is beyond argument that hormone therapy is the main resource of a gynecologist, but it is not always acceptable and does not solve all the problems of normalizing psychoneuroendocrine status. The dependence of functional disorders on environmental stress factors allows a doctor to use lifestyle correction, including rational nutrition and adding various micronutrients, in a program to improve the quality of life, eliminate psychoemotional symptoms and symptoms of autonomic dysfunction. In turn, the restoration of the adaptive reserve of the body becomes key to the recovery of menstrual function.

менструальный циклфертильностьподросткиаменореядисменореяпредменструальный синдромменопаузаприливы жарамикронутриенты

menstrual cyclefertilityadolescentsamenorrheadysmenorrheapremenstrual syndromemenopausehot flashesMicronutrients

References1

Perry J.R.B., Murray A., Day F.R., Ong K.K. Molecular insights into the aetiology of female reproductive ageing. Nat Rev Endocrinol. 2015;11(12):725-734. doi: 10.1038/nrendo.2015.167.

Jung D., Kee K. Insights into female germ cell biology: from in vivo development to in vitro derivations. Asian J Androl. 2015;17(3):415420. doi: 10.4103/1008-682X.148077.

Brown J.B. Types of ovarian activity in women and their significance: The continuum (a reinterpretation of early findings). Hum Reprod Update. 2011;17(2):141-158. doi: 10.1093/humupd/dmq040.

Richards J.S., Ascoli M. Endocrine, Paracrine, and Autocrine Signaling Pathways That Regulate Ovulation. Trends Endocrinol Metab. 2018;29(5):313-325. doi: 10.1016/j.tem.2018.02.012.

Blackwell L.F., Vigil P., Cooke G., d’Arcangues C., Brown J.B. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: Variability of normal menstrual cycle profiles. Hum Reprod. 2013;28(12):3306-3315. doi: 10.1093/humrep/det389.

Prior J.C., Naess M., Langhammer A., Forsmo S. Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles – A Population-Based Cohort from HUNT3, Norway. PLoS One. 2015;10(8):e0134473. doi: 10.1371/journal.pone.0134473.

Vigil P., Lyon C., Flores B., Rioseco H., Serrano F. Ovulation, a sign of health. Linacre Q. 2017;84(4):343-355. doi: 10.1080/00243639.2017.1394053.

Donnez J., Dolmans M.M. Fertility Preservation in Women. N Engl J Med. 2017;377(17):16571665. doi: 10.1056/NEJMra1614676.

Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W., Sherman S., Sluss P.M., de Villiers T.J. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012;97(4):843-851. doi: 10.1016/j.fertnstert.2012.01.128.

O’Connor K.A., Ferrell R., Brindle E., Trumble B., Shofer J., Holman D.J., Weinstein M. Progesterone and ovulation across stages of the transition to menopause. Menopause. 2009;16(6):1178-1187. doi: 10.1097/gme.0b013e3181aa192d.

Unuane D., Tournaye H., Velkeniers B., Poppe K. Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab. 2011;25(6):861873. doi: 10.1016/j.beem.2011.08.001.

Unuane D., Tournaye H., Velkeniers B., Poppe K. Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab. 2011;25(6):861-873. doi: 10.1016/j.beem.2011.08.001.

Clarke H., Dhillo W.S., Jayasena C.N. Comprehensive review on kisspeptin and its role in reproductive disorders. Endocrinol Metab (Seoul). 2015;30(2):124-141. doi: 10.3803/EnM.2015.30.2.124.

Tsutsui K., Bentley G.E., Bedecarrats G., Osugi T., Ubuka T., Kriegsfeld L.J. Gonadotropininhibitory hormone (GnIH) and its control of central and peripheral reproductive function. Front Neuroendocrinol. 2010;31(3):284-95. doi: 10.1016/j.yfrne.2010.03.001.

Борисенко М.Ю., Уварова Е.В., Батырова З.К. Клинико-патогенетические особенности вторичной аменореи у девочек-подростков при нормогонадотропинемии (аналитический обзор). Репродуктивное здоровье детей и подростков. 2014;(3):23–36. Режим доступа: http://rzdp.geotar.ru/cgi-bin/unishell?usr_data=click(cur_user,change_languages(ru,jarticles_repr,322))&SSr=23013416c812ffffffff27c__07e309140c1715-2426.

Borisenko M.Yu., Uvarovа E.V., Batyrova Z.K. Clinical and pathogenetic features of secondary amenorrhea in adolescent girls with normogonadotropinemia (analytical review). Reproduktivnoe zdorov’e detey i podrostkov = Pediatric and Adolescent Reproductive Health. 2014;(3):23–36. (In Russ.) Available at: http://rzdp.geotar.ru/cgi-bin/unishell?usr_data=click(cur_user,change_languages(ru,jarticles_repr,322))&SSr=23013416c812ffffffff27c__07e309140c1715-2426.

Ryu A., Kim T.H. Premenstrual syndrome: A mini review. Maturitas. 2015;82(4):436-440. doi: 10.1016/j.maturitas.2015.08.010.

Toffoletto S., Lanzenberger R., Gingnell M., Sundstrom-Poromaa I., Comasco E. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology. 2014;(50):28-52. doi: 10.1016/j.psyneuen.2014.07.025.

Lokuge S., Frey B.N., Foster J.A., Soares C.N., Steiner M. Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. J Clin Psychiatry. 2011;72(11):e1563-e1569. doi: 10.4088/JCP.11com07089.

Henderson V.W. Memory at midlife: perception and misperception. Menopause. 2009;16(4):635636. doi: 10.1097/gme.0b013e3181a72622.

Skurnick J.H., Weiss G., Goldsmith L.T., Santoro N., Crawford S. Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril. 2009;91(4):1127-1134. doi: 10.1016/j.fertnstert.2008.01.031.

Ziv-Gal A., Flaws J.A. Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt). 2010;19(10):1905-1914. doi: 10.1089/jwh.2009.1852.

Van Reen E., Kiesner J. Individual differences in self-reported difficulty sleeping across the menstrual cycle. Arch Womens Ment Health. 2016;19(4):599-608. doi: 10.1007/s00737-0160621-9.

Shechter A., Lesperance P., Ng Ying Kin N.M., Boivin D.B. Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder. PLoS One. 2012;7(12):e51929. doi: 10.1371/journal.pone.0051929.

Yen J.Y., Chang S.J., Ko C.H., Yen C.F., Chen C.S., Yeh Y.C., Chen C.C. The high-sweet-fat food craving among women with premenstrual dysphoric disorder: emotional response, implicit attitude and rewards sensitivity. Psychoneuroendocrinology. 2010;35(8):12031212. doi: 10.1016/j.psyneuen.2010.02.006.

Gorczyca A.M., Sjaarda L.A., Mitchell E.M., Perkins N.J., Schliep K.C., Wactawski-Wende J., Mumford S.L. Changes in macronutrient, micronutrient, and food group intakes throughout the menstrual cycle in healthy, premenopausal women. Eur J Nutr. 2016;55(3):1181-1188. doi: 10.1007/s00394-015-0931-0.

Draper C.F., Duisters K., Weger B., Chakrabarti A., Harms A.C., Brennan L., Hankemeier T., Goulet L., Konz T., Martin F.P., Moco S., van der Greef J. Menstrual cycle rhythmicity: metabolic patterns in healthy women. Sci Rep. 2018;8(1):14568. doi: 10.1038/s41598-01832647-0.

Feng Q., O’Malley B.W. Nuclear Receptor Modulation – Role of Coregulators in Selective Estrogen Receptor Modulator (SERM) Actions. Steroids. 2014;90:39-43. doi: 10.1016/j.steroids.2014.06.008.

Martinkovich S., Shah D., Lobo Planey S., Arnott J.A. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging. 2014;9:1437-1452. doi: 10.2147/CIA.S66690.

Baber R.J., Panay N., Fenton A., and the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109150. doi: 10.3109/13697137.2015.1129166.

Cardini F., Lesi G., Lombardo F., van der Sluijs C. MSCG – Menopause Survey Collaborative Group. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health. 2010;(10):7. doi: 10.1186/1472-6874-10-7.

NAMS Position Statement. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;22(11):1155-1172; quiz 1173-4. doi: 10.1097/GME.0000000000000546.

Evans M., Elliott J.G., Sharma P., Berman R., Guthrie N. The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study. Maturitas. 2011;68(2):189-196. doi: 10.1016/j.maturitas.2010.11.012.

Imhof M., Gocan A., Imhof M., Schmidt M. Soy germ extract alleviates menopausal hot flushes: placebo-controlled double-blind trial. Eur J Clin Nutr. 2018;72(7):961-970. doi: 10.1038/s41430-018-0173-3.

Henderson V.W., John J.A., Hodis N.H., Kono N., McCleary C.A., Franke A.A., Mack W.J. Longterm soy isoflavone supplementation and cognition in women: A randomized, controlled trial. Neurology. 2012;78(23):1841-1848. doi: 10.1212/WNL.0b013e318258f822.

Портянникова Н.П., Лазарева Н.В., Пикалова М.В., Веревкина О.М. Сравнительная эффективность различных методов терапии климактерического синдрома. Мать и дитя в Кузбассе. 2011;(3):52–55. Режим доступа: https://cyberleninka.ru/article/v/sravnitelnayaeffektivnostrazlichnyh-metodov-terapii-klimaktericheskogosindroma.

Portyannikova N.P., Lazareva N.V., Pikalova M.V., Verevkina O.M. Comparative value of the various therapeutic methods in climacteric syndrome. Mat’ i ditya v Kuzbasse = Mother and Baby in Kuzbass. 2011;(3):52–55. (In Russ.) Available at: https://cyberleninka.ru/article/v/sravnitelnaya-effektivnostrazlichnyhmetodov-terapii-klimaktericheskogosindroma.

Кудина Е.В. Коррекция клинических проявлений климактерического синдрома: роль фитоэстрогенов. Справочник поликлинического врача. 2018;(1–2):12–14. Режим доступа: https://con-med.ru/magazines/physician/physician-01-2018/patsient_s_sinkopalnym_sostoyaniem_na_prieme_u_terapevta_algoritm_obsledovaniya/ .

Kudina E.V. Management of the clinical manifestations of menopausal syndrome: role of phytoestrogens. Spravochnik poliklinicheskogo vracha = Polyclinic Physician’s Reference. 2018;(1–2):12– 14. (In Russ.) Available at: https://con-med.ru/magazines/physician/physician-01-2018/patsient_s_sinkopalnym_sostoyaniem_na_prieme_u_terapevta_algoritm_obsledovaniya/

Gordon C.M., Ackerman K.E., Berga S.L., Kaplan J.R., Mastorakos G., Misra M., Murad M.H., Santoro N.F., Warren M.P. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(5):1413-1439. doi: 10.1210/jc.2017-00131.

Лаврентьева И.В., Сулимов А.В., Обоскалова Т.А. Опыт применения препарата эстровэл у девочек с первичной олигоменореей и сопутствующей неврологической патологией. Репродуктивное здоровье детей и подростков. 2008;(6):50–54. Режим доступа: https://elibrary.ru/item.asp?id=12972610.

Lavrentieva I.V., Sulimov A.V., Oboskalova T.A. The use of drug Estrovel in girls with primary oligomenorrhea and accompanying neurological pathology. Reproduktivnoe zdorov’e detey i podrostkov = Pediatric and Adolescent Reproductive Health. 2008;(6):50–54. (In Russ.) Available at: https://elibrary.ru/item.asp?id=12972610.

Chocano-Bedoya P.O., Manson J.E., Hankinson S.E., Johnson S.R., Chasan-Taber L., Ronnenberg A.G., Bigelow C., Bertone-Johnson E.R. Intake of selected minerals and risk of premenstrual syndrome. Am J Epidemiol. 2013;177(10):11181127. doi: 10.1093/aje/kws363.

Whelan A.M., Jurgens T.M., Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16(3):407–429. Available at: https://www.ncbi.nlm.nih.gov/pubmed/?term=Herbs%2C+vitamins+and+minerals+in+the+treatment+of+premenstrual+syndrome%3A+a+systematic+review.

Nevatte T., O’Brien P.M.S., Backstrom T., Brown C., Dennerstein L., Endicott J., Epperson C.N., Eriksson E., Freeman E.W., Halbreich U., Ismail K., Panay N., Pearlstein T., Rapkin A., Reid R., Rubinow D., Schmidt P., Steiner M., Studd J., Sundstrom-Poromaa I., Yonkers K. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013;16(4): 279-291. doi: 10.1007/s00737-013-0346-y.

Kuo J., Hamid N., Bondar G., Prossnitz E.R., Micevych P. Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J Neurosci. 2010;30(39):12950-12957. doi: 10.1523/JNEUROSCI.1158-10.2010.

Свидинская Е.А., Есина Е.В. Возможности витаминно-минерального комплекса тайм фактор для коррекции нарушений менструального цикла и уменьшения проявлений предменструального синдрома. РМЖ. Мать и дитя. 2015;(14):825–829. Режим доступа: https://www.rmj.ru/articles/ginekologiya/Vozmoghnosti_ispolyzovaniya_vitaminno-mineralynogo_kompleksa_Taym_Faktor_dlya_korrekcii_narusheniy_menstrualynogo_cikla_i_umenysheniya_proyavleniy_predmenstrualynogo_sindroma/.

Svidinskaya E.A., Esina E.V. Vitamin-mineral complex Time Factor options for the management of menstrual irregularities and reduction of manifestations of premenstrual syndrome. RMZH. Mat’ i ditya = RMJ. 2015;(14):825–829. (In Russ.) Available at: https://www.rmj.ru/articles/ginekologiya/Vozmoghnosti_ispolyzovaniya_vitaminno-mineralynogo_kompleksa_Taym_Faktor_dlya_korrekcii_narusheniy_menstrualynogo_cikla_i_umenysheniya_proyavleniy_predmenstrualynogo_sindroma/

Wallace M., Hashim Y.Z., Wingfield M., Culliton M., McAuliffe F., Gibney M.J., Brennan L. Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Hum Reprod. 2010;25(4):949-956. doi: 10.1093/humrep/deq011.

Gupta R., Chattopadhyay D. Glutamate is the chemotaxis-inducing factor in placental extracts. Amino Acids. 2009;37(2):359-366. doi: 10.1007/s00726-008-0162-2.

Hoffman M. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress. Med Hypotheses. 2011;77(6):1088-1093. doi: 10.1016/j.mehy.2011.09.009.

Romani A.M. Magnesium in health and disease. Met Ions Life Sci. 2013;(13):49-79. doi: 10.1007/978-94-007-7500-8_3.

Afsar B., Elsurer R. The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients. J Am Soc Hypertens. 2014;8(1):28-35. doi: 10.1016/j.jash.2013.10.006.

Akinloye O., Adebayo T.O., Oguntibeju O.O., Oparinde D.P., Ogunyemi E.O. Effects of contraceptives on serum trace elements, calcium and phosphorus levels. West Ind Med J. 2011;60(3):308–315. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22224344.

Геворгян А.П., Сибирская Е.В., Адамян Л.B., Арсланян К.Н. Первичная дисменорея девочек-подростков как предиктор развития недифференцированной дисплазии соединительной ткани (обзор литературы). Проблемы репродукции. 2017;23(3):77–85. doi: 10.17116/repro201723377-85.

Gevorgyan A.P., Sibirskaya E.V., Adamyan L.V., Arslanyan K.N. Primary dysmenorrhea in adolescent girls as a predictor of the development of undifferentiated connective tissue dysplasia. Problemy reproduktsii = Russian Journal of Human Reproduction. 2017;23(3):77–85. (In Russ.) doi: 10.17116/repro201723377-85.

Xie C., Li X., Wu J., Liang Z., Deng F., Xie W., Zhu M., Zhu J., Zhu W., Geng S., Zhong C. Antiinflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway. Inflammation. 2015;38(4):1639-1648. doi: 10.1007/s10753-015-0140-2.

Moores J. Vitamin C: a wound healing perspective. Br J Community Nurs. 2013;(Supp. l6):S8–11. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24796079.

Imaeda N., Kuriki K., Fujiwara N., Goto C., Tokudome Y., Tokudome S. Usual dietary intakes of selected trace elements (Zn, Cu, Mn, I, Se, Cr, and Mo) and biotin revealed by a survey of four-season 7-consecutive day weighed dietary records in middle-aged Japanese dietitians. J Nutr Sci Vitaminol. (Tokyo). 2013;59(4):281–288. doi: 10.3177/jnsv.59.281.

Takacs P., Jaramillo S., Zhang Y., Datar R., Williams A., Olczyk J., Candiotti K., Medina C.A. The effects of PPARδ agonist and zinc on ovariectomized rats’ vagina. Female Pelvic Med Reconstr Surg. 2013;19(3):126-131. doi: 10.1097/SPV.0b013e31828746e9.

Takacs P., Jaramillo S., Zhang Y., Datar R., Williams A., Olczyk J., Candiotti K., Medina C.A. The effects of PPAR’ agonist and zinc on ovariectomized rats’ vagina. Female Pelvic Med Reconstr Surg. 2013;19(3):126-131. doi: 10.1097/SPV.0b013e31828746e9.

Кузнецова И.В., Шевелева Т.В., Юсупов М.И. Эффективность витаминно-растительного комплекса в лечении нарушений менструального цикла у молодых женщин. Гинекология. 2013;15(2):29–33. Режим доступа: https://con-med.ru/magazines/gynecology/gynecology-02-2013/effektivnost_vitaminno_rastitelnogo_kompleksa_v_lechenii_narusheniy_menstrualnogo_tsikla_u_molodykh_/.

Kuznetsova I.V., Sheveleva T.V., Yusupov M.I. Effectiveness of the vitaminplant complex in the treatment of menstrual irregularities in young women. Ginekologiya = Gynaecology. 2013;15(2):29–33. (In Russ.) Available at: https://con-med.ru/magazines/gynecology/gynecology02-2013/effektivnost_vitaminno_rastitelnogo_kompleksa_v_lechenii_narusheniy_menstrualnogo_tsikla_u_molodykh_/

Agarwal A., Aponte-Mellado A., Premkumar B.J., Shaman A., Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49. doi: 10.1186/1477-7827-10-49.

Lawlor D.W., Tezara W. Causes of decreased photosynthetic rate and metabolic capacity in waterdeficient leaf cells: a critical evaluation of mechanisms and integration of processes. Ann Bot. 2009;103(4):561-579. doi: 10.1093/aob/mcn244.

Lawlor D.W., Tezara W. Causes of decreased photosynthetic rate and metabolic capacity in water-deficient leaf cells: a critical evaluation of mechanisms and integration of processes. Ann Bot. 2009;103(4):561-579. doi: 10.1093/aob/mcn244.

Wang L.Y., Wang D.H., Zou X.Y., Xu C.M. Mitochondrial functions on oocytes and preimplantation embryos. J Zhejiang Univ Sci B. 2009;10(7):483492. doi: 10.1631/jzus.B0820379.

Wang L.Y., Wang D.H., Zou X.Y., Xu C.M. Mitochondrial functions on oocytes and preimplantation embryos. J Zhejiang Univ Sci B. 2009;10(7):483-492. doi: 10.1631/jzus.B0820379.

Pagano G., Talamanca A.A., Castello G., Cordero M.D., d’Ischia M., Gadaleta M.N., Pallardo F.V., Petrović S., Tiano L., Zatterale A. Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondriatargeted clinical strategies. Oxid Med Cell Longev. 2014:541230. doi: 10.1155/2014/541230.

Pagano G., Talamanca A.A., Castello G., Cordero M.D., d’Ischia M., Gadaleta M.N., Pallardo F.V., Petrović S., Tiano L., Zatterale A. Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev. 2014:541230. doi: 10.1155/2014/541230.

De Groote D., d’Hauterive S.P., Pintiaux A., Balteau B., Gerday C., Claesen J., Foidart J.M. Effects of oral contraception with ethinylestradiol and drospirenone on oxidative stress in women 18-35 years old. Contraception. 2009;80(2):187-193. doi: 10.1016/j.contraception.2009.02.015.

Fares S., Sethom M.M., Khouaja-Mokrani C., Jabnoun S., Feki M., Kaabachi N. Vitamin A, E, and D deficiencies in tunisian very low birth weight neonates: prevalence and risk factors. Pediatr Neonatol. 2014;55(3):196-201. doi: 10.1016/j.pedneo.2013.09.006.

Lebovitz O., Orvieto R. Treating patients with «thin» endometrium – an ongoing challenge. Gynecol Endocrinol. 2014;30(6):409-414. doi: 10.3109/09513590.2014.906571.

Baumgartner M.R. Vitamin-responsive disorders: cobalamin, folate, biotin, vitamins B1 and E. Handb Clin Neurol. 2013;(113):1799-1810. doi: 10.1016/B978-0-444-59565-2.00049-6.

Gurgen S.G., Erdoğan D., Elmas C., Kaplanoğlu G.T., Ozer C. Chemoprotective effect of ascorbic acid, α-tocopherol, and selenium on cyclophosphamideinduced toxicity in the rat ovarium. Nutrition. 2013;29(5):777-784. doi: 10.1016/j.nut.2012.11.004.

Gurgen S.G., Erdoğan D., Elmas C., Kaplanoğlu G.T., Ozer C. Chemoprotective effect of ascorbic acid, α-tocopherol, and selenium on cyclophosphamide-induced toxicity in the rat ovarium. Nutrition. 2013;29(5):777-784. doi: 10.1016/j.nut.2012.11.004.

Zal F., Mostafavi-Pour Z., Amini F., Heidari A. Effect of vitamin E and C supplements on lipid peroxidation and GSH-dependent antioxidant enzyme status in the blood of women consuming oral contraceptives. Contraception. 2012;86(1):62-66. doi: 10.1016/j.contraception.2011.11.006.

Mosley B.S., Cleves M.A., Siega-Riz A.M., Shaw G.M., Canfield M.A., Waller D.K., Werler M.M., Hobbs C.A. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol. 2009;169(1):9-17. doi: 10.1093/aje/kwn331.

The authors declare that there are no conflicts of interest present.